A fund at the frontier of healthcare
Rhenman Healthcare Next Generation L/S is a long biased hedge fund predominantly investing in micro-, small- and mid-cap companies. A fundamentally driven bottom-up approach, with emphasis on companies at the forefront of medical innovation and scientific advancement.
The investment team is supported by a Scientific Advisory Board dedicated to the fund.
Important: For investors in the fund. Past performance is not an guarantee of future returns.
The fund aims to generate an average annual net return of at least 12 percent over time, regardless of the global stock market’s performance.
The portfolio construction is a key component of Next Generation's investment approach, aiming to strike a balance between return and volatility. The portfolio is selective and consists of approximately 60 long positions and 40 short positions, focusing on companies where the managers have high conviction and see clear upside potential. This selective approach means that companies are added to the portfolio when they are assessed to have genuine potential.
"This selective approach means that companies are added to the portfolio when they are assessed to have genuine potential."
Once a company has been added, the position can be gradually increased in size as the investment thesis is confirmed, and reduced or exited if conditions change. The fund has a global investment universe. However, the majority of holdings are in the US, where most of the healthcare industry is based.
We leverage our established infrastructure, proprietary research, and in-house knowledge, complemented by niche expertise, to strengthen economies of scale across strategies.
Retail share class information – Next Generation
| SHARE CLASS | CURRENCY | MINIMUM INVESTMENT | ANNUAL MANAGEMENT + PERF. FEE | ISIN |
| RC1 | SEK | 10 000 | 2.0% + 20% performance fee | LU3247638136 |
| RC2 | SEK | 1 000 000 | 1.5% + 20% performance fee | LU3247638219 |
Institutional share class information – Next Generation
| SHARE CLASS | CURRENCY | MINIMUM INVESTMENT | ANNUAL MANAGEMENT + PERF. FEE | ISIN |
| IC2 | SEK | 25 000 000 | 1.0% + 18% performance fee | LU3247639027 |
| IC1 | EUR | 250 000 | 1.5% + 18% performance fee | LU3247638649 |
| IC2 | EUR | 2 500 000 | 1.0% + 20% performance fee | LU3247639373 |
| IC1 | USD | 250 000 | 1.5% + 18% performance fee | LU3247638995 |
| IC2 | USD | 2 500 000 | 1.0% + 18% performance fee | LU3247639456 |
For more detailed information please refer to the prospectus which can be found through our document library. There you can also find performance scenarios.
If you have any questions or would like access to fund fact sheets (KIDs), please send an email to info@rhepa.com
Fund management
Rhenman Healthcare Next Generation L/S ("Next Generation") is managed by ONE Fund Management S.A., who have commissioned Rhenman & Partners to manage the fund's portfolio.
Rhenman & Partners is authorized to conduct securities operations in the form of discretionary portfolio management regarding financial instruments. This means that Rhenman & Partners manages the fund’s portfolio, i.e. buys and sells securities within the framework of the fund’s investment regulations. However, we do not provide investment advice. Investors who are considering investing in the fund are strongly recommended to discuss investment questions with a professional investment advisor. For more information regarding the fund’s legal structure, please refer to the prospectus and the fund fact sheets.
